The Daily Byte
Breaking
Welcome to The Daily Byte — real stories from across Pakistan.
Saturday, 21 November 2026 · Pakistan

The Daily Byte

Stories from Pakistan that deserve to be heard
Minor UK News

Boots Launches SureLeaf Medical Cannabis Service

By aminah ·16 Nov 2026 ·3 min read
The blue Boots pharmacy and beauty storefront on a UK high street

Boots has launched a private medical cannabis service, SureLeaf, through Boots Online Doctor, offering consultant-led assessment and prescribing to eligible patients living with long-term health conditions.

The service, which began on Monday 16 November, is for patients aged 25 and over with chronic pain, generalised anxiety disorder or insomnia who have already tried conventional treatments without achieving adequate symptom relief. It is a private service and is not part of the NHS.

Patients begin with an online assessment. Suitability is reviewed by the clinical team before they move on to a video consultation with a consultant in the relevant medical specialty who is on the General Medical Council Specialist Register. Any proposed prescription is independently reviewed by a multidisciplinary clinical team, including a second, independent consultant, before treatment begins.

How SureLeaf works

Once treatment starts, patients receive ongoing clinical support and monitoring, with an initial review after 28 days and further reviews at least every three months. Validated questionnaires are used throughout to assess quality of life, pain, anxiety, sleep and mood.

A one-month trial costs £89 and includes the initial assessment, a 10ml starter dose of cannabis oil and a check-in at the end of the month. An annual plan costs £99 and includes the initial assessment and four follow-up appointments. Medicines are charged separately, with flower available from £38 and oil from £35. The service offers 11 cannabis flower products and four oils.

Eligible chronic pain conditions include fibromyalgia, neuropathic pain, osteoarthritis, chronic migraine and endometriosis-related pelvic pain, alongside generalised anxiety disorder and insomnia disorder. Patients must have tried at least two conventional treatments, such as prescription drugs or psychotherapy, before cannabis is considered.

Boots says safeguards come first

Jamie Kerruish, chief healthcare officer at Boots, said millions of people live with ongoing pain and that for some, conventional treatments do not provide adequate symptom relief. He said SureLeaf gives eligible patients another treatment option to consider, supported by clinical expertise and robust ongoing care.

Dr David Gwynne, medical director at Boots Online Doctor, said medical cannabis is not appropriate for everyone and that prescribing decisions need to be made carefully on an individual patient basis. He said the service was designed with strong clinical safeguards and specialist oversight at every stage.

Boots is also exploring a research programme with the University of Nottingham to build evidence on medical cannabis in chronic pain management, looking at patient outcomes, prescribing practices and patient experiences.

Eight years after legalisation

Medical cannabis has been legal on prescription in the UK since November 2018, when prescribed by an approved specialist. LBC, which first reported the launch, described Boots as the first UK high street pharmacy to privately prescribe cannabis.

Patients considering the service should check the full eligibility criteria on the Boots Online Doctor website. Whether treatment is appropriate is a decision for the treating clinicians, and a private prescription does not mean the treatment would be available through the NHS.

Source: Retail Times, reporting the Boots Online Doctor announcement and The Pharmacist.